Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
multiple sclerosis
Marketing
Biogen investigated by Italian regulator on ‘market abuse’ claims
Italy’s antitrust agency is investigating Biogen over claims it is abusing its market position regarding a test for MS drug Tysabri.
Ben Adams
May 27, 2026 7:38am
Merck KGaA expects Mavenclad generics to deal serious blow in US
Mar 5, 2026 11:30am
Roche eyes busy 2026 despite Vabysmo miss, Tecentriq flop
Jan 29, 2026 11:23am
Fierce Biotech
FDA shares CRL for Sanofi MS drug mere weeks after rebuff
Jan 6, 2026 4:30am
Genentech uncovers 'Hidden GeMS' in latest #MSVisibility drive
Dec 9, 2025 4:05pm
Sandoz's biosimilar to Biogen's Tysabri hits the US after delay
Nov 17, 2025 11:12am
Fierce Biotech
Fierce Biotech
Fierce Biotech
Fierce Biotech
